Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Enochian Biosciences Inc (ENOB)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Revenues | 100.0% | 100.0% | | | | | 100.0% | |
| Cost of goods sold | 100.0% | 36.9% | | | | | 12.3% | |
| Gross profit | 0.0% | 63.1% | | | | | 87.7% | |
| Research and development | 207.7% | 42.0% | | | | | 1880.3% | |
| General and administrative | 355.4% | 20.7% | | | | | 2875.6% | |
| EBITDA | -491.3% | -70.4% | | | | | -4895.0% | |
| Depreciation | 3.1% | 0.3% | | | | | 64.1% | |
| EBIT | -494.3% | -70.7% | | | | | -4959.0% | |
| Pre-tax income | -2813.7% | -71.8% | | | | | -5139.3% | |
| Income taxes | 0.0% | -0.3% | | | | | -1082.1% | |
| Net income | -2813.7% | -71.5% | | | | | -4057.2% | |
|